Historic Shares Outstanding (Weighted Average) for Nuvation Bio (NUVB) over the last 5 years, with Jun 2025 value amounting to $340.3 million.
- Nuvation Bio's Shares Outstanding (Weighted Average) rose 37.66% to $340.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $340.3 million, marking a year-over-year increase of 37.66%. This contributed to the annual value of $336.6 million for FY2024, which is 53.72% up from last year.
- Nuvation Bio's Shares Outstanding (Weighted Average) amounted to $340.3 million in Q2 2025, which was up 0.47% from $338.7 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Shares Outstanding (Weighted Average) registered a high of $340.3 million during Q2 2025, and its lowest value of $217.7 million during Q1 2021.
- In the last 3 years, Nuvation Bio's Shares Outstanding (Weighted Average) had a median value of $233.1 million in 2024 and averaged $260.6 million.
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 1,253.97% in 2021, then dropped by 0.12% in 2023.
- Quarterly analysis of 5 years shows Nuvation Bio's Shares Outstanding (Weighted Average) stood at $217.8 million in 2021, then increased by 0.28% to $218.4 million in 2022, then climbed by 0.25% to $218.9 million in 2023, then soared by 53.72% to $336.6 million in 2024, then spiked by 37.66% to $340.3 million in 2025.
- Its Shares Outstanding (Weighted Average) stands at $340.3 million for Q2 2025, versus $338.7 million for Q1 2025 and $336.6 million for Q4 2024.
